KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.

MLA

Li, Jinyuan, et al. “KRT17 Confers Paclitaxel-Induced Resistance and Migration to Cervical Cancer Cells.” Life Sciences, vol. 224, May 2019, pp. 255–62. EBSCOhost, https://doi.org/10.1016/j.lfs.2019.03.065.

APA

Li, J., Chen, Q., Deng, Z., Chen, X., Liu, H., Tao, Y., Wang, X., Lin, S., & Liu, N. (2019). KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells. Life Sciences, 224, 255–262. https://doi.org/10.1016/j.lfs.2019.03.065

Chicago

Li, Jinyuan, Qiufang Chen, Zhendong Deng, Xiaoting Chen, Hong Liu, Ying Tao, Xiaoyu Wang, Shaoqiang Lin, and Naihua Liu. 2019. “KRT17 Confers Paclitaxel-Induced Resistance and Migration to Cervical Cancer Cells.” Life Sciences 224 (May): 255–62. doi:10.1016/j.lfs.2019.03.065.